PsyRx CNS Bio-Tech (XTAE:PSRX) Probability of Financial Distress (%)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:PSRX PsyRx CNS Bio-Tech Ltd XTAE:PSRX
10 GF Score
Price ₪0.73
! 1 Warning Sign
View Full Analysis

What is PsyRx CNS Bio-Tech Probability of Financial Distress (%)?

PsyRx CNS Bio-Tech does not have enough data to calculate Probability of Financial Distress (%).

PsyRx CNS Bio-Tech  (XTAE:PSRX) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

PsyRx CNS Bio-Tech Probability of Financial Distress (%) Related Terms

PsyRx CNS Bio-Tech Probability of Financial Distress (%) Historical Data

* Premium members only.

The historical data trend for PsyRx CNS Bio-Tech's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyRx CNS Bio-Tech Probability of Financial Distress (%) Chart

PsyRx CNS Bio-Tech Annual Data
Trend
Probability of Financial Distress (%)

PsyRx CNS Bio-Tech Semi-Annual Data
Probability of Financial Distress (%)

XTAE:PSRX vs ZTS, UTHR, VTRS: Probability of Financial Distress (%) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PsyRx CNS Bio-Tech's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PsyRx CNS Bio-Tech Probability of Financial Distress (%) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PsyRx CNS Bio-Tech's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where PsyRx CNS Bio-Tech's Probability of Financial Distress (%) falls into.


XTAE:PSRX
10GF Score
PsyRx CNS Bio-Tech Ltd XTAE:PSRX
Probability of Financial Distress (%) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PsyRx CNS Bio-Tech Business Description

Address Arik Einstein 3, Herzliya, ISR, 4610301
PsyRx CNS Bio-Tech Ltd Formerly Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.
10GF Score

Get the complete analysis for XTAE:PSRX

Probability of Financial Distress (%) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.73
Price